Periodontal Hastalıkların Tedavisinde Lokal Antibiyotik Kullanımı.

1 Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018;89 Suppl 1:S159-S172. doi: 10.1002/JPER.18-0006

Olsen I, Singhrao SK. Importance of heterogeneity in Porhyromonas gingivalis lipopolysaccharide lipid A in tissue specific inflammatory signalling. J Oral Microbiol. 2018;10(1):1440128. Published 2018 Feb 26. doi:10.1080/20002297.2018.1440128

Graves DT, Jiang Y, Valente AJ. The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. Front Biosci. 1999;4:D571-D580. Published 1999 Jul 1. doi:10.2741/graves

Uchida M, Shima M, Shimoaka T, et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol. 2000;185(2):207-214. doi:10.1002/1097-4652(200011)185:2<207::AID-JCP5>3.0.CO;2-J

Isola G, Polizzi A, Alibrandi A, Williams RC, Leonardi R. Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels. J Periodontol. 2021;92(6):896-906. doi:10.1002/JPER.20-0242

Shinwari MS, Tanwir F, Hyder PR, et al. Host modulation therapeutics in periodontics: role as an adjunctive periodontal therapy. J Coll Physicians Surg Pak. 2014;24(9):676-684.

Carranza FA, Klokkevold PR. Host Modulation Agents. In: Newman MG, Takei HH, Carranza FA, editors. Clinical Periodontology. Philadelphia: W.B. Saunders Comp. 2007:811-27

Khattri S, Kumbargere Nagraj S, Arora A, et al. Adjunctive systemic antimicrobials for the non-surgical treatment of periodontitis. Cochrane Database Syst Rev. 2020;11(11):CD012568. doi:10.1002/14651858.CD012568.pub2

Zandbergen D, Slot DE, Niederman R, et al. The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: =a systematic review=. BMC Oral Health. 2016;16:27. doi:10.1186/s12903-015-0123-6

Szulc M, Zakrzewska A, Zborowski J. Local drug delivery in periodontitis treatment: A review of contemporary literature. Dent Med Probl. 2018;55(3):333-342. doi:10.17219/dmp/94890

Goodson JM, Cugini MA, Kent RL, et al. Multicenter evaluation of tetracycline fiber therapy: I. Experimental design, methods, and baseline data. J Periodontal Res. 1991;26(4):361-370. doi:10.1111/j.1600-0765.1991.tb02075.x

Chuenbarn, T., Chantadee, T., Phaechamud, T. Doxycycline hyclate-loaded Eudragit® RS PO in situ-forming microparticles for periodontitis treatment. Journal of Drug Delivery Science and Technology. 2022; 71,103294.

Kornman KS. Controlled-release local delivery antimicrobials in periodontics: prospects for the future. J Periodontol. 1993;64(8 Suppl):782-791. doi:10.1902/jop.1993.64.8s.782

Yusri S, Elfana A, Elbattawy W, et al. Effect of locally delivered adjunctive antibiotics during surgical periodontal therapy: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(9):5127-5138. doi:10.1007/s00784-021-04056-7

Herrera D, Matesanz P, Martín C, et al. Adjunctive effect of locally delivered antimicrobials in periodontitis therapy: A systematic review and meta-analysis. J Clin Periodontol. 2020;47 Suppl 22:239-256. doi:10.1111/jcpe.13230

Etienne D. Locally delivered antimicrobials for the treatment of chronic periodontitis. Oral Dis. 2003;9 Suppl 1:45-50. doi:10.1034/j.1601-0825.9.s1.8.x

Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232-260. doi:10.1128/MMBR.65.2.232-260.2001

Nelson ML, Levy SB. Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein. Antimicrob Agents Chemother. 1999;43(7):1719-1724. doi:10.1128/AAC.43.7.1719

Mani, A., Mani, S., Manerikar, R., et al. Antimicrobial agents in Periodontics: A review. Annals of the Romanian Society for Cell Biology. 2020; 801-808.

Bonito AJ, Lux L, Lohr KN. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review (published correction appears in J Periodontol. 2006 Feb;77(2):326) JPeriodontol.2005;76(8):1227-1236. doi:10.1902/jop.2005.76.8.1227

Slim, L., Arora, S. A., Gilani, F. Efficacy Of Low Dose Doxycycline In The Treatment Of Periodontal Disease-A Systematic Review. National Journal of Integrated Research in Medicine, 2021; 12(4).

Das AC, Das SJ, Panda S, et al. Adjunctive Effect of Doxycycline with Conventional Periodontal Therapy on Glycemic Level for Chronic Periodontitis with Type 2 Diabetes Mellitus Subjects. J Contemp Dent Pract. 2019;20(12):1417-1423.

Phaechamud T, Thurein SM, Chantadee T. Role of clove oil in solvent exchange-induced doxycycline hyclate-loaded Eudragit RS in situ forming gel. Asian J Pharm Sci. 2018;13(2):131-142. doi:10.1016/j.ajps.2017.09.004

Jain SK, Jain AK, Rajpoot K. Expedition of Eudragit® Polymers in the Development of Novel Drug Delivery Systems. Curr Drug Deliv. 2020;17(6):448-469. doi:10.2174/1567201817666200512093639

H R R, Dhamecha D, Jagwani S, et al. Local drug delivery systems in the management of periodontitis: A scientific review. J Control Release. 2019;307:393-409. doi:10.1016/j.jconrel.2019.06.038

Chou SF, Carson D, Woodrow KA. Current strategies for sustaining drug release from electrospun nanofibers. J Control Release. 2015;220(Pt B):584-591. doi:10.1016/j.jconrel.2015.09.008

Joshi D, Garg T, Goyal AK, et al. Advanced drug delivery approaches against periodontitis. Drug Deliv. 2016;23(2):363-377. doi:10.3109/10717544.2014.935531

Dodwad V, Ahuja S, Kukreja BJ. Effect of locally delivered tetracycline hydrochloride as an adjunct to scaling and root planing on Hba1c, C-reactive protein, and lipid profile in type 2 diabetes: A clinico-biochemical study. Contemp Clin Dent. 2012;3(2):150-154. doi:10.4103/0976-237X.96816

Khan FY, Jan SM, Mushtaq M. Clinical utility of locally-delivered collagen-based biodegradable tetracycline fibers in periodontal therapy: an in vivo study. J Investig Clin Dent. 2015;6(4):307-312. doi:10.1111/jicd.12111

Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50 Suppl 1:S16-S23. doi:10.1086/647939

Eiding J. Metronidazole-containing gels and creams for external use in the treatment of rosacea. Deutsche Apotheker Zeitung. 2004;144:52–3.

Szentmihályi, K., May, Z., Bódis, E., et al. Morphology transformation of thermosensitive metronidazol by spray freeze-drying. Journal of Thermal Analysis and Calorimetry, 2022; 147(21), 11777-11786.

Goolsby TA, Jakeman B, Gaynes RP. Clinical relevance of metronidazole and peripheral neuropathy: a systematic review of the literature. Int J Antimicrob Agents. 2018;51(3):319-325. doi:10.1016/j.ijantimicag.2017.08.033

Soysa, N. S., Waidyarathne, H., Ranaweera, M., et al. Clinical efficacy of local application of sustained-release metronidazole in periodontal therapy. Dentistry Review. 2021; 1(1), 100006.

Yadav SK, Khan G, Mishra B. Advances in patents related to intrapocket technology for the management of periodontitis. Recent Pat Drug Deliv Formul. 2015;9(2):129-145. doi:10.2174/1872211309666150311095424